-
Animal & Veterinary
-
Antimicrobial Resistance Public Meeting
October 2, 2002
On October 2, 2002, FDA's Center for Veterinary Medicine (CVM) convened a public meeting to discuss the "Draft Guidance for Industry: Evaluating the Safety of Antimicrobial New Animal Drugs with Regards to Their Microbiological Effects on Bacteria of Human Health Concern." The meeting was held at the DoubleTree Holtel in Rockville, MD.
-
Meeting Materials
- Agenda - Antimicrobial Resistance Public Meeting, 10/02/2002
- Presentation - Ranking of Antimicrobial Drugs According to Importance in Human Medicine
John H. Powers, M.D., Lead Medical Officer, Antimicrobial Drug Development and Resistance Initiatives, Office of Drug Evaluation IV, CDER/FDA - Presentation - Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern
David G. White, Mary J. Bartholomew, FDA
-
-
Guidance and Federal Register Notices
- CVM GFI #152 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern (PDF - 131KB)
- Notice: Draft Guidance - Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern
- Notice of Public Meeting: Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern
-
-
-